Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
PhenoMiner Database Result        View data table  |  Download data table  |  View compact data table        


Generate Chart For    
    (Chart displayed below)
Rat Strains

{{sample.term}}
Measurement Methods

{{method.term}}
Age

{{ageRange}}
Experimental Conditions

     {{ cond }}

Minimum Value:    Maximum Value:    Sex:


 
Options:  View chart  |  Download data table  |  View compact data table
Study IDStudyExperiment NameExperiment NotesStrain Ont IDStrainSexAge# of AnimalsSample NotesClinical Measurement Ont IDPhenotypeFormulaClinical Measurement NotesAverage TypeValueUnitsSEMSDMethod Ont IDMethodMethod SiteMethod DurationMethod NotesPost Insult TypePost Insult Time ValuePost Insult Time UnitConditionsRecord IDCondition 1aCondition 1b
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days11CMO:0001400maximum body weight loss to initial body weight ratio9.6%1.44.6433MMO:0000016body weighing method0.0squalene (200 ul) 69795squalene (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001400maximum body weight loss to initial body weight ratio5.9%3.713.8441MMO:0000016body weighing method0.0Freund's complete adjuvant (100 ul) 69797Freund's complete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001400maximum body weight loss to initial body weight ratio2.8%1.03.7417MMO:0000016body weighing method0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69799type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.body massRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days16CMO:0001400maximum body weight loss to initial body weight ratio8.8%2.28.8MMO:0000016body weighing method0.0pristane (150 ul) 69805pristane (150 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days16CMO:0001453percentage of study population developing experimental arthritis during a period of time69%MMO:0000163in vivo visual assessment0.0pristane (150 ul) 69718pristane (150 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days11CMO:0001453percentage of study population developing experimental arthritis during a period of time73%MMO:0000163in vivo visual assessment0.0squalene (200 ul) 69705squalene (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001453percentage of study population developing experimental arthritis during a period of time36%MMO:0000163in vivo visual assessment0.0Freund's complete adjuvant (100 ul) 69708Freund's complete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001453percentage of study population developing experimental arthritis during a period of time71%MMO:0000163in vivo visual assessment0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69711type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1301Ribbhammar U, et al., Hum Mol Genet 2003 Sep 1;12(17):2087-96.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both0 days7CMO:0001453percentage of study population developing experimental arthritis during a period of time0%MMO:0000163in vivo visual assessment0.0Freund's incomplete adjuvant (200 ul) 84874Freund's incomplete adjuvant (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days11CMO:0001450post-insult time to onset of experimental arthritis16d0.41.3266MMO:0000163in vivo visual assessment0.0squalene (200 ul) 69774squalene (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001450post-insult time to onset of experimental arthritis13.6d0.41.4967MMO:0000163in vivo visual assessment0.0Freund's complete adjuvant (100 ul) 69776Freund's complete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days14CMO:0001450post-insult time to onset of experimental arthritis17.6d0.82.9933MMO:0000163in vivo visual assessment0.0type II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69779type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.joint integrity traitRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both200 days to 120 days16CMO:0001450post-insult time to onset of experimental arthritis13.1d1.14.4MMO:0000163in vivo visual assessment0.0pristane (150 ul) 69786pristane (150 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both180 days to 120 days11CMO:0001466serum orosomucoid 1 level790mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assaysqualene (200 ul) 69752squalene (200 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both180 days to 120 days14CMO:0001466serum orosomucoid 1 level370mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assayFreund's complete adjuvant (100 ul) 69755Freund's complete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both180 days to 120 days14CMO:0001466serum orosomucoid 1 level500mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assaytype II collagen (500 ug) and Freund's incomplete adjuvant (100 ul) 69758type II collagen (500 ug) Freund's incomplete adjuvant (100 ul)
1162Backdahl L, et al., Arthritis Rheum 2003 Feb;48(2):551-9.orosomucoid 1 amountblood alpha-1-acid glycoprotein amountRS:0000227DA.PVG.1AV1-(D4Rat155-D4Rat84)both180 days to 120 days16CMO:0001466serum orosomucoid 1 level750mg/lMMO:0000439radial immunodiffusion assay0.0radial immunodiffusion assaypristane (150 ul) 69765pristane (150 ul)